Clinical Trials Browser

Polycystic Ovary Syndrome

NCT05756764 2025-09-09

Anti-obesity Pharmacotherapy and Inflammation

Active not recruiting

30 enrolled

Other

Inflammation, Obesity, Metabolic Syndrome, Dyslipidemias

NCT06742710 2025-05-29

LITOP

Phase 4 Recruiting

890 enrolled

Other

Infertility, Obesity, Polycystic Ovary Syndrome

NCT06217848 2024-01-23

The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study

Phase EARLY_PHASE1 Unknown

50 enrolled

CNSEndocrine

Combined Pituitary Hormone Deficiency, Craniopharyngioma, Sexual Infantilism

NCT05952882 2023-10-23

Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility

Phase 3 Unknown

188 enrolled

Other

Infertility, Female, Insulin Resistance, Obesity, Polycystic Ovary Syndrome, Weight Loss

NCT03480022 2021-06-07

SAXAPCOS

Phase 3 Completed

88 enrolled 35 charts

Other

Polycystic Ovary Syndrome, Prediabetic State, Weight Loss, Glucose Intolerance, Obesity, Abdominal

NCT02073929 2019-02-28

LIPT

Phase 4 Completed

72 enrolled 18 charts

Cardiovascular Diseases, Polycystic Ovary Syndrome

NCT02909933 2016-09-21

Low Dose Liraglutide and Metformin vs. High Dose Liraglutide Alone in Treatment of Obesity

Phase 4 Completed

30 enrolled

Other

Obesity, Polycystic Ovary Syndrome

NCT02475499 2016-03-14

Incretin-based Drugs and Pancreatic Cancer

Completed

886,172 enrolled

Gastrointestinal

Diabetes Mellitus, Type 2, Pancreatic Neoplasms

Clinical Trials

Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome

Anti-obesity Pharmacotherapy and Inflammation

LITOP

The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study

Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility

SAXAPCOS

LIPT

Low Dose Liraglutide and Metformin vs. High Dose Liraglutide Alone in Treatment of Obesity

Incretin-based Drugs and Pancreatic Cancer